Mapmygenome Acquires Microbiome Insights to Expand Genomics Services

May 29, 2025
Mapmygenome has acquired Microbiome Insights, enhancing its capabilities in microbial sequencing and expanding its presence in North America.

Mapmygenome has announced the strategic acquisition of Microbiome Insights, a leader in microbial sequencing, announced in a press release. This acquisition includes Microbiome Insights' CAP-accredited laboratory in Canada and its extensive intellectual property, which will bolster Mapmygenome's scientific capabilities and support its global expansion.

Microbiome Insights, known for supporting over 600 global clients with more than 1,000 microbiome studies, will continue to operate as a premier contract research organization (CRO). This move allows Mapmygenome to introduce its integrated genomics and microbiome testing services to North America, making comprehensive health solutions more accessible.

Anu Acharya, Founder and CEO of Mapmygenome, highlighted the importance of the human microbiome in health, stating that the acquisition positions the company as a leader in this field. The integration of expertise in metagenomics, transcriptomics, and targeted metabolomics will serve academic, biotech, and clinical sectors, aligning with Mapmygenome's strategic vision for growth through targeted acquisitions.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Funding News Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Funding

08/02
Caseflood Secures $3.2M to Advance AI Voice Agents for Law Firms
08/02
Salesforce and ServiceNow Invest $1.5 Billion in Genesys
08/02
Legion Security Secures $30 Million Series A for AI SOC Platform
08/02
Knit Secures $16.1M Series A for AI-Driven Enterprise Research
08/02
Noma Security Secures $100M for AI Agent Security Expansion

More from: Life Sciences

08/02
Core Solutions Introduces AI-Powered EHR Platform for Behavioral Health
08/02
Codoxo to Showcase AI Innovations at 2025 NAMPI Conference
08/01
Ultromics Secures $55M for AI Heart Failure Diagnostics
07/31
Human Longevity Expands AI-Driven Lung Cancer Detection Initiative
07/31
C8 Health Secures $12M for AI-Powered Healthcare Platform

Subscribe to AI Funding Brief

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like